350 likes | 485 Views
Pharmacotherapy for Diabetic Coronary Disease: . Trials Targeting Lower HbA 1c Levels. VADT: CV Risk Factor Control. Look AHEAD: Lifestyle Intervention Did Not Reduce Hard End Points . UKPDS: Metformin and Outcomes in New T2D at 36 Months.
E N D
Look AHEAD: Lifestyle Intervention Did Not Reduce Hard End Points
VADT: Intensive Treatment Reduces CVD Events in Cases With Lower Calcified Coronary Atherosclerosis
SAVOR-TIMI 53: Hypoglycemia by Baseline Medication and HbA1c